Drugs / ACE2 CAR-NK cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04324996 | Feb 2020 → Feb 2022 | COVID-19 | Chongqing Public Health Medical Center | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACE2 CAR-NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04324996 ↗ |